Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: J Urol. 2015 Jan 6;193(6):1950–1955. doi: 10.1016/j.juro.2014.12.091

Figure 3.

Figure 3

Estimated risk of reclassification in compliant patients after 2 years of active surveillance. Number of biopsies at end of 2 years varied even in compliant patients based on interval between biopsies. A, Gleason score. B, any biopsy criteria.